Literature DB >> 14622141

Over-expression of a novel nuclear interactor of Suppressor of fused, the Drosophila myelodysplasia/myeloid leukaemia factor, induces abnormal morphogenesis associated with increased apoptosis and DNA synthesis.

Sylvaine Fouix1, Séverine Martin-Lannerée, Matthieu Sanial, Luciana Morla, Claudie Lamour-Isnard, Anne Plessis.   

Abstract

BACKGROUND: In Drosophila and vertebrates, suppressor of fused (Su(fu)) proteins act as negative regulators of the Gli/Ci transcription factors, which mediate the transcriptional effects of Hh signalling.
RESULTS: We sought for novel partners of Su(fu) in fly using the two-hybrid method. Most of the Su(fu) interactors thus identified are (or are likely to be) able to enter the nucleus. We focused on one of these putative partners, dMLF, which resembles vertebrate myelodysplasia/myeloid leukaemia factors 1 and 2. We demonstrate that dMLF binds specifically to Su(fu) in vitro and in vivo. Using a novel anti-dMLF antibody, we showed, that dMLF is a nuclear, chromosome-associated protein. We over-expressed a dMLF transgene in fly using an inducible expression system and showed that dMLF over-expression disrupts normal development, leading to either a lethal phenotype or adult structural defects associated with apoptosis and increased DNA synthesis. Furthermore, the dMLF-induced eye phenotype is enhanced by the loss of Su(fu) function, suggesting a genetic interaction between Su(fu) and dMLF.
CONCLUSION: We propose that dSu(fu) and dMLF act together at the transcriptional level to coordinate patterning and proliferation during development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622141     DOI: 10.1046/j.1365-2443.2003.00685.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  8 in total

1.  Multisite interaction with Sufu regulates Ci/Gli activity through distinct mechanisms in Hh signal transduction.

Authors:  Yuhong Han; Qing Shi; Jin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

2.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

3.  Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.

Authors:  Vanessa Gobert; Marc Haenlin; Lucas Waltzer
Journal:  Transcription       Date:  2012-09-01

4.  A quantification of pathway components supports a novel model of Hedgehog signal transduction.

Authors:  Shohreh F Farzan; Melanie A Stegman; Stacey K Ogden; Manuel Ascano; Kendall E Black; Ofelia Tacchelly; David J Robbins
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

5.  TRF4 is involved in polyadenylation of snRNAs in Drosophila melanogaster.

Authors:  Ryoichi Nakamura; Ryo Takeuchi; Kei-ichi Takata; Kaori Shimanouchi; Yoko Abe; Yoshihiro Kanai; Tatsushi Ruike; Ayumi Ihara; Kengo Sakaguchi
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

6.  Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.

Authors:  Stéphanie Bras; Séverine Martin-Lannerée; Vanessa Gobert; Benoît Augé; Osman Breig; Matthieu Sanial; Masamitsu Yamaguchi; Marc Haenlin; Anne Plessis; Lucas Waltzer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

7.  Drosophila myeloid leukemia factor acts with DREF to activate the JNK signaling pathway.

Authors:  H Yanai; Y Yoshioka; H Yoshida; Y Nakao; A Plessis; M Yamaguchi
Journal:  Oncogenesis       Date:  2014-04-21       Impact factor: 7.485

8.  Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis.

Authors:  Marion Miller; Aichun Chen; Vanessa Gobert; Benoit Augé; Mathilde Beau; Odile Burlet-Schiltz; Marc Haenlin; Lucas Waltzer
Journal:  PLoS Genet       Date:  2017-07-25       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.